The Na + -K + pump in the erythrocytes of a mordibly obese patient shows a unique constellation of functional abnormalities. The number of pump units, measured by [ 3 H]ouabain binding to intact cells, as well as the enzymatic activity of the (Na + -K + )-dependent ATPase in erythrocyte membranes were found to be markedly increased compared with control cells (18-fold and 14-fold, respectively). There was a concomitant fivefold increase in the rate of pump-mediated uptake of 86 Rubidium (a K analogue); this was balanced by an increased rate of 86 Rb efflux. In striking contrast to normal cells, however, a major portion of this efflux (80%) was inhibited by ouabain, and thus appeared to be mediated by the Na + -K + pump.
A B S T R A C T The Na+-K+ pump in the erythrocytes of a mordibly obese patient shows a unique constellation of functional abnormalities. The number of pump units, measured by [3H]ouabain binding to intact cells, as well as the enzymatic activity of the (Na+-K+)-dependent ATPase in erythrocyte membranes were found to be markedly increased compared with control cells (18-fold and 14-fold, respectively). There was a concomitant fivefold increase in the rate of pump-mediated uptake of 86Rubidium (a K analogue); this was balanced by an increased rate of 86Rb efflux.
In striking contrast to normal cells, however, a major portion of this efflux (80%) was inhibited by ouabain, and thus appeared to be mediated by the Na+-K+ pump.
Erythrocytes from this patient had elevated levels of intracellular K+ and reduced levels of intracellular Na+. This finding, taken together with the ouabain inhibition of K+ efflux and the absence of associated abnormalities, argues against the possibility that the increased number of Na+-K+ pump units was a compensation for a primary increase in the permeability of the erythrocyte membrane to monovalent cations, as is seen in a variety of erythrocyte disorders. Further evidence for a primary abnormality of the enzyme was our observation that the cardiac glycoside ouabain bound to these cells with reduced affinity and had a right shifted dose response for pump inhibition. The markedly increased number of Na+-K+ pump units in these cells did not appear to extend to mononuclear leukocytes.
In conclusion, the erythrocytes from this patient have a very large number of functionally abnormal 
INTRODUCTION
The Na+-K+ ATPase is the enzymatic equivalent of the membrane Na+ pump (1, 2) . Investigations of the normal physiology and biochemistry of the pump have often used the erythrocyte as a model system, because of easy availability and simplicity of the study of this cell type. In addition, erythrocytes have been used in experiments seeking to define abnormalities of this important membrane enzyme in disease. Alterations in the numbers of erythrocyte pump units and pump activity have been described in a variety of abnormal states. Thus, groups of obese (3), or hyperthyroid (4)1 humans have fewer erythrocyte Na+-K+ ATPase units than their thin, euthyroid controls, and patients with such varied conditions as protein-calorie malnutrition (5) and Huntington's disease (6) have increased activity of the erythrocyte Na+-K+ ATPase. Hemolytic syndromes such as hereditary spherocytosis (7), and hereditary stomatocytosis (8, 9) are also characterized by an increase in the erythrocyte complement and activity of the sodium-potassium pump, and these changes appear to be compensatory for an unknown primary defect causing increased cellular permeability to monovalent cations. Both, uremia (10) , and liver disease (11) have been associated with changes in the sodium pump activity of erythrocytes. In these various syndromes the Na+-K+ pump itself has been shown (or assumed) to function normally, except possibly in myotonic muscular dystrophy (12) , where an altered stoichiometry of Na+ and K+ pumping may exist. We wish to report a patient with morbid obesity whose erythrocytes display grossly abnormal cation pumping activity in the absence of other erythrocyte abnormality. Erythrocytes from this patient have a very large (18-fold) increase in the number of Na+-K+ ATPase units, and those pump units that are present demonstrate a unique functional abnormality.
METHODS
Case report. The subject (M.A.J.) is a 45-yr-old woman whose presenting medical complaint was marked obesity. The patient had been heavier than her peers from age 8 yr onwards, and at the time of the initial presentation she weighed 147 kg. With her height of 165 cm, she was considered to be 152% above her ideal body weight (Metropolitan Life Insurance Company tables).
Her previous history included three pregnancies, one of which resulted in a stillbirth. She had an ovarian cystectomy and a cholecystectomy 12 and 10 yr, respectively, before presentation. Apart from her obesity, she was otherwise well, and in particular showed no carbohydrate intolerance or hypertension. Because her obesity had repeatedly proven refractory to dietary treatment, she underwent a gastric stapling operation in December 1979 and subsequently lost 54 kg over a 12-mo period. Apart from this weight loss, there appeared to be no other effects of the surgery and specifically she showed no electrolyte or hematologic abnormalities and there was no clinical or biochemical evidence of hepatic dysfunction. Her drug intake at the time of the studies consisted of multivitamin supplements.
Family history was remarkable for the fact that both her parents and two sisters were of normal weight. There was no history of any hematologic disorder in any member of the family.
Studies on the Na+-K+ pump of her erythrocytes were performed on four separate occasions over a 12-mo period subsequent to the gastric bypass surgery.
Limited studies of the Na+-K+ pump of erythrocytes from two sons of the patient were also carried out. Both were in normal health. The elder of the two (J.A.S) was mCi/mg, New England Nuclear) and increasing concentrations of ouabain (0-0.1 mM). The buffer used contained 140 mM NaCl, 10 mM Tris. 1.6 mM RbCl, 10 mM dextrose, pH 7.40. We have shown that in normal cells the rate of Rb uptake mediated by the Na+-K+ pump is linear with time over a period of 4 h (data not shown) and the experiments were routinely stopped at 1 h of incubation at 37°C. The cells were washed three times in 140 mM ice-cold choline chloride and intracellular radioactivity was then measured after precipitation of protein by 5% TCA. To measure 'Rb efflux from erythrocytes, cell were preincubated with 86Rb for 5 hs at 370C, washed repeatedly with 140 mM choline chloride and then resuspended in tracer-free buffer of the same composition as stated above. When indicated, ouabain was present at a final concentration of 0.1 mM. The appearance of "Rb in the supernatant was measured at 20-min intervals for 60 min and related to total intracellular radioactivity at time zero of the efflux period.
Na+-K+ ATPase activity of erythrocyte membranes. 5 ml of packed erythrocytes were osmotically lysed in 10 vol of ice-cold 5 mM Tris/0.1 mM disodium EDTA, pH 7.6. The membranes were centrifuged at 20,000 g for 20 min at 4°C. They were then washed three times in 0.017 M NaCl/5 mM Tris, pH 7.6 and three times with 10 mM Tris (pH 7.45) and the hemoglobin-free membrane suspension was stored in this last buffer at -20°C until assay of Na+-K+ ATPase activity (3-4 d 
RESULTS
Hematologic data are presented in Table I . Erythrocyte indices are within normal limits, and there are no findings that might suggest reduced erythrocyte lifespan or subtle tendency to hemolysis, such as reticulocytosis, stomatocytosis (9), or altered osmotic fragility.
A saturation curve of ouabain binding to erythrocytes from the patient and from control individuals demonstrates that the total amount of ouabain specifically bound to M.A.J. erythrocytes is much higher than control values at all concentrations of ouabain ( Fig. 1) . By extrapolation of these curves to saturating concentrations of ouabain, the maximal ligand binding capacity of M.A.J. cells can be calculated to be -18-fold higher than controls. The curve shown represents one individual study; this and three other studies in this patient gave a mean value for binding capacity of 10.44±1.23 pmol of ouabain/109 cells (compared with a control value of 0.596±0.109 pmol/109 cells that corresponds to -360 pump units/cell). The ouabain binding curve also shows that the affinity of the patient's cells for ouabain is reduced, since the concentration of the ligand at which 50% of the available sites are saturated under the experimental conditions used is 15.4±2.0 nM for the patient and 6.6±1.3 nM for controls.
The uptake of rubidium by patient and control cells is shown in Fig. 2 . Both the total hourly uptake and the uptake inhibited by 0.1 mM ouabain are markedly increased in the patient's cells, whereas the uptake in the presence of 0.1 mM ouabain (i.e. nonpump-mediated) is even lower in her cells, although the lowering is not significant. Again, these data represent one particular study and the mean value for Na+-K+ pump- mediated Rb uptake by the patient's cells in the four studies performed was 451±55 nmol/109 cells per h compared with a control value of 83.5±10.2 nmol/109 cells per h. The uptake data also provides further indication of a decrease in the affinity of the pump for ouabain, since the concentration of ouabain at which uptake of Rb is inhibited by 50% is -fourfold higher with M.A.J. cells (380 vs. 86 nM) (Fig. 2) .
It would be expected that a marked increase in Rb uptake by M.A.J. cells should be balanced by an equivalent increase in the rate of Rb efflux from these cells. That such is indeed the case is shown in Fig. 3 . The fractional rate of release of 86Rb from cells preloaded with the isotope is much higher in the patient's cells (rate constants of 0.0719 h-' and 0.0276 h-' in patient and controls, respectively). The effect of ouabain on 86Rb efflux was also assessed (Fig. 3) . Whereas samples of blood obtained from M.A.J. and four control samples treated identically and processed simultaneously. It may be noted that the control values for erythrocyte Na+ and K+ differ from our previously published levels (3), as a result of an unavoidable change in methodology. However, the significance of relative differences seen both here and in our previous publication still obtain.
In addition to the lowered intracellular sodium levels in freshly obtained M.A.J. erythrocytes, ouabain blockade of the pump for 5 h resulted in only a 3 mM increase in the intracellular sodium concentration (compared with a mean increase of 3.3 mM in the cells from the four control subjects). In these respects, these cells differ from those seen in hemolytic syndromes associated with increased permeability of the erythrocyte membrane to Na+, in which erythrocyte Na levels are consistently increased and rise dramatically when the activity of the Na+-K+ pump is inhibited (9) .
The Na+-K+ ATPase activity of erythrocyte membranes is also markedly elevated in this patient (Table  III) . In contrast, another integral membrane protein, the insulin receptor, appears to be normal in erythrocytes from the affected subject (Table II) .
The binding of [3H] ouabain to a population of circulating mononuclear leukocytes was also assessed ( Functional Abnormality of Erythrocyte Na+-K+ Pump (18, 19) . Increased activity of the pump has been noted in situations where the permeability of the erythrocyte membrane to Na+ and/or K+ is increased leading to "downhill" movement of the two ions. The cell will then attempt to reestablish the normal gradient by increasing the activity of the Na+-K+ pump, as well as by increasing the number of pump units per cell. This appears to be the case in various hemolytic syndromes such as stomatocytosis (9) , where increased pump levels and activity are seen in cells with abnormally high sodium levels. That our patient does not represent a variant of these syndromes is indicated by the absence of any of the hematologic features seen in this group of patients (e.g. anemia due to accelerated hemolysis, reticulocytosis, abnormal osmotic fragility and cell morphology) and by the repeated observation that her erythrocyte sodium levels have always been significantly lower than normal, rather than increased, as is the case in the aforementioned conditions. Thus, a primary increase in the inward leak of Na+, eventually leading to increased Na+-K+ pump activitity does not appear to be the defect in M.A.J. erythrocytes, since this would necessarily result in higher than normal intracellular sodium levels. Similarly, a primary increase in the "leak" of K+ from the cells could be envisaged as resulting in an increased pump activity to restore intracellular K+ levels towards normal. However, the data shown in Fig.  3 argue against this possibility since they show that the K+ "leak" (i.e. the rate of efflux of 86Rb from cells with a blocked Na+-K+ pump) is actually lower in this particular patient than in controls.
The biochemical basis for the cation transport abnormality in these cells is unknown. As discussed above, the available evidence argues against the increase in pump units and activity being a compensation for increased leakiness of the erythrocyte membrane for Na+ or K+. In our view, the most likely explanation for the transport abnormality in this patient is a primary or secondary abnormality in the Na+-K+ ATPase enzyme molecule, leading to altered affinities for ions and ouabain, and a secondary increase in pump units. Structural mutations in this important enzyme have not been previously described in man. Of great interest is the fact that the number of pump units on mononuclear leukocytes of this patient is in the normal range. This might serve as indirect evidence for separate genes encoding for the Na+-K+ ATPase of different tissues. Other evidence favoring this concept already exists in that antigenic differences between enzymes from different tissues have been described (20) .
The relationship of this finding to our previbus observation (3) that obese individuals as a group have fewer pump units per erythrocyte than nonobese individuals is also unknown. Taken together with our previous data (3), we have now identified five obese individuals in whom the number of erythrocyte pump units exceeds that of any normal control and is at least 2 SD higher than the mean control value. One of these subjects is the younger son of our patient, data for whom are reported in Table III . It is very tempting to speculate that the abnormality described may have a genetic familial basis although obviously more extensive family studies will be needed to confirm such a hypothesis. Whether these individuals with high erythrocyte Na+-K+ ATPase levels represent a subgroup of obese patients with a distinctly important abnormaiity of the enzyme, or whether the pump abnormality in these cases is unrelated to their obesity also remains to be determined.
In conclusion, we have demonstrated a unique functional abnormality in the erythrocyte Na+-K+ ATPase of a morbidly obese patient. Further studies of this defective pump may provide important information on the normal biochemical mechanism underlying activity of this critical membrane system.
